Pralidoxime

Protopam Chloride - (PWS 1G/Vial)

1 G / VIAL Powder For SolutionCanadaCancelledAuthorised 25 Oct 1996

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Protopam ChlorideUnited States · 1GM/VIAL · injectable · Baxter Hlthcare CorpSame brand
Protopam ChlorideUnited States · 500MG · tablet · Wyeth AyerstSame brand
ContrathionItaly · Polvere e solvente per soluzione per infusione endovenosa · Serb S.A.SSame substance
AnyNew Zealand · Inj 25 mg per ml, 20 ml ampouleSame substance
Oxidote 1GM VialSaudi Arabia · Tabuk Pharmaceutical Manufacturing Co./ Dammam PlantSame substance
PretavaSaudi Arabia · Hikma Italia SPASame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pralidoxime

Protopam Chloride - (PWS 1G/Vial)

1 G / VIAL Powder For SolutionCanadaCancelledAuthorised 25 Oct 1996

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

PAM-A INJECTION 500 mg/ampouleSingapore · 500 mg/ampoule · injection, powder, lyophilized, for solution · Shoei Universal Corporation Pte LTD

Pralidoxime ChlorideUnited States · 1GM/VIAL, 300MG/ML · injectable · Baxter Hlthcare Corp

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Pralidoxime
Strength: 1 G / VIAL
Dosage form: Powder For Solution
Route: Intramuscular, Intravenous, Subcutaneous
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 25 Oct 1996
Registration: DIN 02043475
Marketing authorisation holder: Wyeth Canada
ATC code: V03AB04
Group: Various
Supply: PRESCRIPTION